Tarek Hammoud - 17 Oct 2022 Form 4 Insider Report for Enfusion, Inc.

Role: 10%+ Owner
Signature: /s/ Tarek Hammoud
Issuer symbol: N/A
Transactions as of: 17 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 19 Oct 2022, 19:41:46 UTC
Previous filing: 26 Apr 2022
Next filing: 15 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENFN	Class A Common Stock	Conversion of derivative security		+1,000,000			1,000,000	17 Oct 2022	See footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENFN	Common Units of Enfusion Ltd. LLC	Conversion of derivative security	$0	-1,000,000	-8.4%	$0.000000	10,870,386	17 Oct 2022	Class A Common Stock	1,000,000		See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock are exchangeable for shares of the issuer's Class A common stock on a one-for-one basis with the issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
F2	These Common Units are held by LRA Ventures, LLC. Tarek Hammoud is the sole manager of LRA Ventures, LLC, an estate planning vehicle. Mr. Hammoud may be deemed to have dispositive power over the securities held by LRA Ventures, LLC. Mr. Hammoud disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.